CD19 Molecule (CD19) (C-Term) Peptid
CD19
Reaktivität: Human
Wirt: Synthetic
BP, WB
-
- Target Alle CD19 Produkte
- CD19 (CD19 Molecule (CD19))
- Protein Region
- C-Term
- Spezies
- Human
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB)
- Sequenz
- RGILYAAPQL RSIRGQPGPN HEEDADSYEN MDNPDGPDPA WGGGGRMGTW
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-CD19 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- CD19 (CD19 Molecule (CD19))
- Hintergrund
-
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Alias Symbols: B4, CVID3
Protein Size: 557 - Gen-ID
- 930
- NCBI Accession
- NM_001178098, NP_001171569
-
Sie sind hier:
